Gilead Sciences
GILD
#131
Rank
A$229.69 B
Marketcap
A$185.00
Share price
-0.82%
Change (1 day)
3.64%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2026 (TTM): A$16.03 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are A$29.73 Billion. In 2025 the company made an earning of A$13.91 Billion, an increase over its 2024 earnings that were of A$0.98 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$16.03 B15.17%
2025 A$13.91 B1319.86%
2024 A$0.98 B-89.94%
2023 A$9.74 B17.97%
2022 A$8.26 B-29.77%
2021 A$11.76 B395.99%
2020 A$2.37 B-67.66%
2019 A$7.33 B-33.84%
2018 A$11.08 B-42.35%
2017 A$19.22 B-20.87%
2016 A$24.29 B-21.06%
2015 A$30.77 B45.8%
2014 A$21.10 B253.01%
2013 A$5.97 B16.51%
2012 A$5.13 B-1.07%
2011 A$5.18 B-6.71%
2010 A$5.56 B11.75%
2009 A$4.97 B29.5%
2008 A$3.84 B19.11%
2007 A$3.22 B-455.74%
2006 -A$0.91 Billion-154.93%
2005 A$1.65 B76.99%
2004 A$0.93 B-266.16%
2003 -A$0.57 Billion-638.24%
2002 A$0.10 B31.5%
2001 A$79.3 M-242.15%
2000 -A$55.8 Million-40.2%
1999 -A$93.3 Million31.85%
1998 -A$70.76 Million8.73%
1997 -A$65.08 Million27.22%
1996 -A$51.15 Million
1994 -A$48.74 Million26.57%
1993 -A$38.51 Million46.49%
1992 -A$26.29 Million362.5%
1991 -A$5.69 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.91 B 142.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$15.04 B-1.28%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$8.48 B-44.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$44.22 B 190.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.91 B-15.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.30 B-84.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$1.64 B-89.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$7.19 B-52.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$18.68 B 22.60%๐Ÿ‡บ๐Ÿ‡ธ USA